CAS 12656-61-0
:Cerebrolysin
Description:
Cerebrolysin is a neuropeptide preparation derived from porcine brain tissue, primarily composed of low molecular weight peptides and amino acids. It is classified as a nootropic agent, often used in clinical settings to support cognitive function and neuroprotection. The substance is believed to enhance neuronal metabolism, promote neurogenesis, and exert antioxidant effects, making it potentially beneficial in conditions such as Alzheimer's disease, stroke, and traumatic brain injury. Cerebrolysin is administered via injection and is known for its ability to cross the blood-brain barrier, facilitating its action on the central nervous system. Its pharmacological profile includes neurotrophic and neuroprotective properties, which may help in the recovery of cognitive functions and improve overall brain health. While it is generally well-tolerated, potential side effects can include allergic reactions and injection site discomfort. As with any therapeutic agent, its use should be guided by a healthcare professional, considering the specific clinical context and patient needs.
Formula:Unspecified
Synonyms:- Cerebrolysin Concentrate
- Cerebrolysine
- Fpe 1070
- Cerebrolysin
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.
Cerebrolysin
CAS:Peptide mixture from porcine brain; neuroprotective effects. Consists of low-weight neuropeptides which are no larger than 10,000 Da.
Purity:Min. 95%Color and Shape:Powder
